Relinase La 50 MG Injection

Relinase La 50 MG Injection is a medication that is used in the treatment of mental disorders such as mood behavior disorders, schizophrenia and schizoaffective disorders and hallucinations. It has also shown to reduce aggression and the desire to commit suicide or bring harm to others.

On using Relinase La 50 MG Injection some side effects may occur which are; diarrhea, dizziness, drowsiness, headache, decrease in appetite, headache, stomach upset, restlessness and nausea. Take precaution by informing your physician if:

• You are pregnant or thinking about becoming pregnant.
• You are breastfeeding a baby.
• You are under any kind of medication, prescriptive, over the counter, herbal, vitamins or dietary supplements.
• You are allergic to any medicine or food.
• You have a history of heart diseases.
• You have porphyria or low blood pressure.
• You have a history of dementia, Alzheimer disease or seizures.
• You are alcoholic.

Seek help from your health care provider if the following severe side effects manifests and continues; allergic skin reactions, fuzzy vision, difficulty in speech, uncontrolled sweating, rapid heartbeat, trouble breathing, darkening of your urine, fever, stiffening of muscles, decreased libido, reduced sperm production and enlargement of breasts .

Relinase La 50 MG Injection needs to be injected into your body. It should be done by trained hands. Do not buy the medication if it is discoloured or slightly cloudy. If you miss one of your doses try to take it as soon as possible. But do not overdose by clubbing the two at the same time.

When you are on Relinase La 50 MG Injection do not drink alcohol. Avoid exposure to the sun or extreme heat. Keep this medication stored between 15 to 30 degrees C. It should be kept away from the reach of children.

Use exactly as directed (do not increase dose or frequency); may cause physical and/or psychological dependence. It may take 2-3 weeks to achieve desired results; do not discontinue without consulting prescriber.

Dilute oral concentration with water or juice. Do not take within 2 hours of any antacid. Store away from light. Avoid excess alcohol or caffeine and other prescription or OTC medications not approved by prescriber.

Maintain adequate hydration (2-3 L/day of fluids unless instructed to restrict fluid intake). Avoid skin contact with medication; may cause contact dermatitis (wash immediately with warm, soapy water).

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Neurologist before using this medicine.

• Schizophrenia

• Tourette Syndrome

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Neurologist before using this medicine.

• Allergy

  Not recommended in patients with known allergy to Relinase La 50 MG Injection

• Central Nervous System Depression

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Neurologist before using this medicine.

• Hypotension

• Restlessness

• Anxiety

• Insomnia

• Agitation

• Drowsiness

• Depression

• Lethargy

• Headache

• Confusion

• Vertigo

• Seizures

• Hyperpigmentation

• Pruritus

• Rash

• Contact Dermatitis

• Alopecia

• Photosensitivity

• Nausea

• Vomiting

• Urinary Retention

• Blurred Vision

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Neurologist before using this medicine.

• How long is the duration of effect?

  The effect of this medicine lasts for an average duration of 2 to 4 weeks

• What is the onset of action?

  The effect of this medicine can be observed in 30 to 60 minutes after an intravenous or intramuscular dose

• Are there any pregnancy warnings?

  This medicine is not recommended for pregnant women. Use only if clearly needed when no safer alternative is available.

• Is it habit forming?

  No habit forming tendency has been reported

• Are there any breast-feeding warnings?

  This medicine is known to be excreted in human breast milk. It is not recommended for breastfeeding women. Use only if clearly needed when no safer alternative is available.

• Is It safe with alcohol?

  It is found to be unsafe to consume alcohol while taking this medicine.

• Is it safe to drive while on this medicine?

  This drug might affect the consciousness of the patient. Thus patient must avoid driving while taking this medicine.

• Does this affect kidney function?

  Limited information is available regarding its use in patient with kidney disease. Kindly consult your doctor before taking it.

• Does this affect liver function?

  Limited information is available regarding its use in patient with liver disease. Kindly consult your doctor before taking it.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Neurologist before using this medicine.

Below is the list of medicines, which have the same composition, strength and form as Relinase La 50 MG Injection , and hence can be used as its substitute.

• Senorm L.A. 50 MG Injection

  Sun Pharma Laboratories Ltd

• Serenace 50 MG Injection

  Rpg Life Sciences Ltd

• Trancodol La 50 MG Injection

  Intas Pharmaceuticals Ltd

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Neurologist before using this medicine.

• Missed Dose instructions

  Take the missed dose as soon as you remember. If it’s almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

• Are there any overdose instructions?

  Seek emergency medical treatment or contact the doctor in case of an overdose.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Neurologist before using this medicine.

• India

• United States

• Japan

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Neurologist before using this medicine.

Relinase La 50 MG Injection belongs to the class antipsychotics. It works by binding to the dopamine D2 receptors and inhibits the release of chemical substances thus helps in reducing the symptoms.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Neurologist before using this medicine.

Whenever you take more than one medicine, or mix it with certain foods or beverages, you"re at risk of a drug interaction.

test

• Interaction with Alcohol

  Alcohol

  Consumption of alcohol with this medicine is not recommended as it can result in dizziness and difficulty in concentration. Avoid activities that need mental alertness like driving and operating machinery.

  Consumption of alcohol with this medicine is not recommended as it can result in dizziness and difficulty in concentration. Avoid activities that need mental alertness like driving and operating machinery.

• Interaction with Lab Test

  Lab

  Information not available.

• Interaction with Medicine

  • Benztropine (and other anticholinergics) may inhibit the therapeutic response to Relinase La 50 MG Injection and excess anticholinergic effects may occur.
  • Chloroquine may increase Relinase La 50 MG Injection concentrations.
  • Cigarette smoking may enhance the hepatic metabolism of Relinase La 50 MG Injection. Larger doses may be required compared to a nonsmoker.
  • Concurrent use of Relinase La 50 MG Injection with an antihypertensive may produce additive hypotensive effects.
  • Concurrent use with TCA may produce increased toxicity or altered therapeutic response.
  • Relinase La 50 MG Injection may inhibit the antiparkinsonian effect of levodopa; avoid this combination.
  • Relinase La 50 MG Injection plus lithium may rarely produce neurotoxicity.
  • Barbiturates may reduce Relinase La 50 MG Injection concentrations.
  • Propranolol may increase Relinase La 50 MG Injection concentrations.
  • Sulfadoxine-pyrimethamine may increase Relinase La 50 MG Injection concentrations.
  • Relinase La 50 MG Injection and CNS depressants (ethanol, narcotics) may produce additive CNS depressant effects.
  • Relinase La 50 MG Injection and trazodone may produce additive hypotensive effects.
  • Carbamazepine appears to stimulate the metabolism of Relinase La 50 MG Injection. Monitor for reduced efficacy.
  • Fluoxetine and paroxetine may inhibit the metabolism of Relinase La 50 MG Injection resulting in EPS; monitor for EPS.
  • Relinase La 50 MG Injection in combination with indomethacin may result in drowsiness, tiredness, and confusion; monitor for adverse effects.
  • Quinidine appears to increase Relinase La 50 MG Injection concentrations; monitor for EPS.

• Interaction with Food

  Food

  Information not available.

• Interaction with Disease

  • Hypotension may occur, particularly with parenteral administration. Decanoate form should never be administered I.V. Avoid in thyrotoxicosis. May be sedating, use with caution in disorders where CNS depression is a feature.
  • Caution in patients with hemodynamic instability, predisposition to seizures, subcortical brain damage, renal or respiratory disease. Esophageal dysmotility and aspiration have been associated with antipsychotic use - use with caution in patients at risk of pneumonia (ie, Alzheimer's disease).
  • Caution in breast cancer or other prolactin-dependent tumors (may elevate prolactin levels). May alter temperature regulation or mask toxicity of other drugs due to antiemetic effects.
  • May alter cardiac conduction - life-threatening arrhythmias have occurred with therapeutic doses of antipsychotics. Adverse effects of decanoate may be prolonged.
  • May cause orthostatic hypotension - use with caution in patients at risk of this effect or those who would tolerate transient hypotensive episodes (cerebrovascular disease, cardiovascular disease, or other medications which may predispose). Some tablets contain tartrazine.
  • May cause extrapyramidal reactions, including pseudoparkinsonism, acute dystonic reactions, akathisia, and tardive dyskinesia (risk of these reactions is high relative to other neuroleptics). May be associated with neuroleptic malignant syndrome (NMS) or pigmentary retinopathy.

• Ques : Is Relinase La 50 MG Injection a controlled drug or narcotic or addictive?

  Ans : No,Relinase La 50 MG Injection is not a controlled drug, narcotic or addictive.

• Ques : Is Relinase La 50 MG Injection a benzo or a neuroleptic or MAOI?

  Ans : No,Relinase La 50 MG Injection is not benzo or MAOI or a neuroleptic. It is antipsychotic. It works by blocking the action of dopamine receptors in brain, which decreases the excessive dopamine activity in the brain.

• Ques : Is Relinase La 50 MG Injection used for nausea?

  Ans : No,Relinase La 50 MG Injection is not used for nausea.

• Ques : Is Relinase La 50 MG Injection a sedative/ make you sleepy?

  Ans : Yes,Relinase La 50 MG Injection can cause sedation.

• Ques : Can you take Relinase La 50 MG Injection with lorazepam?

  Ans : Relinase La 50 MG Injection interacts with lorazepam to cause increased sedation and impaired attention. Please consult your doctor before taking Relinase La 50 MG Injection with diazepam.

• Ques : Does Relinase La 50 MG Injection cause weight gain or does Relinase La 50 MG Injection cause tardive dyskinesia?

  Ans : Yes, in some people Relinase La 50 MG Injection may cause weight gain and tardive dyskinesia

• Ques : Does Relinase La 50 MG Injection cause respiratory depression/ hallucination?

  Ans : Relinase La 50 MG Injection may cause dyspnea as well as other behavioral abnormalities in patients. It is not known to cause respiratory depression/ hallucination.

• Haloperidol-Drug Information Portal [Internet].druginfo.nlm.nih.gov 2022 [Cited 4 June 2022].Available from:

  https://druginfo.nlm.nih.gov/drugportal/name/haloperidol

• Haloperidol-DrugBank Online [Internet].go.drugbank.com 2022 [Cited 4 June 2022].Available from:

  https://go.drugbank.com/drugs/DB00502

• HALOPERIDOL tablet,solution-DailyMed [Internet].dailymed.nlm.nih.gov 2022 [Cited 4 June 2022].Available from:

  https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=HALOPERIDOL